Frederiksberg, Denmark

Flemming M Poulsen


Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • DK-2000 Frederiksberg, DK (2005)
  • Frederiksberg, DK (2008)

Company Filing History:

goldMedal2 out of 832,718 
Other
 patents

Years Active: 2005-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Flemming M Poulsen: Innovator in NCAM Binding Compounds

Introduction

Flemming M Poulsen is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that interact with the neural cell adhesion molecule (NCAM). With a total of two patents to his name, Poulsen's work has the potential to impact treatments for various neurological conditions.

Latest Patents

Flemming M Poulsen's latest patents focus on NCAM binding compounds. The first patent describes novel compounds capable of stimulating the proliferation and outgrowth of cells that present NCAM. This invention also includes methods for treating normal, degenerated, and damaged NCAM-presenting cells. The second patent reiterates similar findings, emphasizing the pharmaceutical compositions, medicaments, and treatment methods associated with these NCAM binding compounds.

Career Highlights

Throughout his career, Poulsen has demonstrated a commitment to advancing medical science through innovative research. His work on NCAM binding compounds showcases his ability to bridge the gap between basic research and practical applications in medicine.

Collaborations

Flemming M Poulsen has collaborated with esteemed colleagues such as Lars Christian Ronn and Arne Holm. These partnerships have likely contributed to the depth and breadth of his research endeavors.

Conclusion

Flemming M Poulsen is a distinguished inventor whose work on NCAM binding compounds holds promise for future medical treatments. His contributions to biotechnology reflect a dedication to improving health outcomes through innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…